Milestone Pharmaceuticals Announces First European Patient Enrolled In Phase 3 Trial Of Etripamil For Atrial Fibrillation With Rapid Heart Rate

뉴스 본문을 불러오고 있어요.

Milestone Pharmaceuticals Announces First European Patient Enrolled In Phase 3 Trial Of Etripamil For Atrial Fibrillation With Rapid Heart Rate | 웨이프 WAPE

Milestone Pharmaceuticals Announces First European Patient Enrolled In Phase 3 Trial Of Etripamil For Atrial Fibrillation With Rapid Heart Rate

기사 요약

관련 종목

댓글 —